Products and services are converging into 'experience cocktails,' blending physical goods with human-mediated interactions. This shift is e...

New diabetes and obesity drugs, like Mounjaro and Ozempic, are changing people's relationships with food. While these drugs help control di...

Novo Nordisk has introduced its weight-loss drug, Wegovy, in India. This launch follows Eli Lilly's entry into the market. The company aims...

Mounjaro, a weight-loss drug by Eli Lilly, saw a huge jump in sales after its India launch. Sales of Mounjaro injections increased signific...

India faces a growing obesity crisis, exacerbated by ultra-processed food consumption and aggressive marketing. Pharmaceutical companies ar...

A new study into GLP-1RA drugs provides previously unknown insights into the impact this class of drugs may have on eating habits. The stud...

World Health Day 2025: Obesity is fast becoming a public health crisis in India, with forecasts showing 440 million Indians could be obese ...

Mounjaro, a newly launched weight-loss and diabetes drug, is now available in India. Developed by Eli Lilly, it promises more effectiveness...

Eli Lilly Weight Loss Drug: India's obesity crisis is intensifying, with big pharma companies like Eli Lilly and Novo Nordisk competing to ...

Regular eating of meat, especially red and processed meat, has been associated in a recent study with an increased risk of type 2 diabetes....

People are going to great lengths to obtain popular weight-loss drugs. They are stashing injectables in their carry-on luggage, buying coun...

U.S. companies in various sectors, including food and beverage, medical devices, and dialysis services, are facing questions from investors...

Nestlé, the global food leader, is responding to the growing trend of appetite-suppressing weight-loss medications like Ozempic, Wegovy, an...